Tufts slims Q2 operating loss to $40.7M under new CFO

Boston-based Tufts Medicine posted a $40.7 million operating loss (-7.9% margin) for the three months ended June 30, improving on the $61.9 million loss (-9.6% margin) reported in the same period during 2023, according to financial documents published Aug. 30.

Read the full post on Becker's Hospital Review | Healthcare News & Analysis